Study Looking at Biomarkers in Ovarian Cancer

  • End date
    Jun 8, 2026
  • participants needed
  • sponsor
    University Health Network, Toronto
Updated on 26 February 2022
ovarian cancer


This is a sample study that will collect biological samples (blood, tumor tissue, ascites, and/or other fluids) from gynecological cancer patients for biomarker research. In addition, the results of the testing done on the samples will be given to the participant's treating physician who may use the information to guide treatment decisions.

Condition Gynecologic Cancer
Treatment Blood sample collection, Fluid collection, Tumour tissue collection, Ascites Collection
Clinical Study IdentifierNCT03419689
SponsorUniversity Health Network, Toronto
Last Modified on26 February 2022


Yes No Not Sure

Inclusion Criteria

Histological diagnosis of stage III or IV high grade serous ovarian, tubal or primary peritoneal cancer
Must be 18 years of age or older
Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1
Have a life expectancy greater than or equal to 6 months
Able to provide adequate informed consent
Willing to undergo blood or fluid collection and tumour biopsy
Patients enrolled at the time of surgery must agree to have part of their tumour used for the purpose of the study
Archival tissue must be available for patients that are enrolled at the time of progression

Exclusion Criteria

Must not have early stage (I and II) high grade serous, tubal or primary peritoneal cancer
Must not have other tumour histology other than high grade serous
Must not have contraindication to tumour biopsy and/or blood sampling
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note